Opportunity Information: Apply for CDC RFA PS13 130105CONT17
Apply for CDC RFA PS13 130105CONT17
- The HHS-CDC-NCHHSTP in the health sector is offering a public funding opportunity titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116.
- This funding opportunity was created on Jun 09, 2016 and posted on Jun 09, 2016.
- Applicants must submit their applications by Aug 01, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands" is a continuation cooperative agreement administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC), specifically through the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). It is identified by Funding Opportunity Number CDC RFA PS13-130105CONT17 and is classified under the health funding activity category, with CFDA number 93.116. The overall intent is to sustain and strengthen public health capacity and program implementation aimed at preventing new infections, improving early detection, and enhancing control efforts for HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the U.S. Affiliated Pacific Islands, where geographic isolation, limited clinical and laboratory infrastructure, and workforce constraints can make surveillance, testing, treatment, and outbreak response more difficult.
Because this is labeled as a continuation opportunity, it is generally designed to extend or support ongoing work rather than launch an entirely new, open competition. In practice, continuation cooperative agreements typically align with previously funded program goals and performance expectations, and they emphasize maintaining momentum in core prevention and control activities already underway. The "cooperative agreement" instrument type is also important: it usually indicates substantial involvement by CDC beyond standard grant oversight. That can include close technical assistance, collaborative planning, support for implementing evidence-based interventions, help with strengthening surveillance and laboratory systems, and guidance on meeting federal program standards for disease reporting, quality assurance, and evaluation.
Eligibility is listed as "Others," with a note indicating that applicants must consult an additional eligibility field in the full announcement for clarification. In many CDC continuation actions, eligibility can be limited to current recipients or entities operating the existing program in the jurisdiction, which fits the continuation designation and the lack of publicly stated expected award counts. The opportunity record shows an award ceiling of 0, which often appears in system postings when the ceiling is not specified in that particular summary record, when budgets vary by recipient, or when funding levels are determined through continuation negotiations and appropriations rather than a single fixed cap. Likewise, the expected number of awards is not provided in the summary, which is common for continuation notices where the recipient pool is already established.
Key administrative details include an original and current closing date of August 1, 2016, with the opportunity created and posted on June 9, 2016. Those dates indicate a time-limited window for whatever continuation application package, progress reporting, or renewal documentation CDC required for that funding cycle. In summary, this funding opportunity represents CDC's continued investment in integrated, multi-disease public health efforts across HIV/AIDS, viral hepatitis, STDs, and TB in the U.S. Affiliated Pacific Islands, using a cooperative agreement structure that supports sustained implementation, technical collaboration, and strengthening of core public health systems needed to prevent transmission and improve disease control outcomes in those jurisdictions.
FAQs: Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands (CDC RFA PS13-130105CONT17)
What is the title of this grant opportunity?
The opportunity is titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands."
Which agency is offering this funding?
This is a U.S. Department of Health and Human Services (HHS) opportunity administered by the Centers for Disease Control and Prevention (CDC), through the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS13-130105CONT17.
What CFDA number is associated with this opportunity?
The CFDA number listed is 93.116.
What funding activity category does this fall under?
The opportunity is classified under the health funding activity category.
What is the overall purpose or intent of the funding?
The overall intent is to sustain and strengthen public health capacity and program implementation to prevent new infections, improve early detection, and enhance prevention and control efforts for HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) in the U.S. Affiliated Pacific Islands.
Which diseases and program areas are covered?
This opportunity supports integrated work across HIV/AIDS, viral hepatitis, STDs, and TB, including efforts related to prevention, surveillance, testing, treatment-related public health activities, and outbreak response support as part of strengthening disease control systems.
What geographic area does this opportunity focus on?
The focus is on the U.S. Affiliated Pacific Islands.
Why is this funding important for the U.S. Affiliated Pacific Islands?
The summary notes that geographic isolation, limited clinical and laboratory infrastructure, and workforce constraints can make surveillance, testing, treatment, and outbreak response more difficult in these jurisdictions. The funding is intended to help sustain and strengthen the core public health systems needed to address those challenges.
Is this an open competition or a continuation award?
It is labeled as a continuation cooperative agreement opportunity, which generally means it is intended to extend or support ongoing work rather than launch a brand-new, open competition.
What does "continuation" typically mean in practice?
Based on the description provided, continuation opportunities typically align with previously funded program goals and performance expectations and emphasize maintaining momentum in core prevention and control activities that are already underway.
What type of award instrument is this?
The instrument type is a cooperative agreement.
What does a cooperative agreement imply about CDC involvement?
The cooperative agreement structure usually indicates substantial CDC involvement beyond standard grant oversight. The summary describes possible CDC roles such as technical assistance, collaborative planning, support for implementing evidence-based interventions, assistance strengthening surveillance and laboratory systems, and guidance on meeting federal program standards for disease reporting, quality assurance, and evaluation.
Who is eligible to apply?
Eligibility is listed as "Others," with a note that applicants must consult an additional eligibility field in the full announcement for clarification.
Does the continuation designation affect who can apply?
Yes. The summary explains that, in many CDC continuation actions, eligibility can be limited to current recipients or entities operating the existing program in the jurisdiction, which would be consistent with the continuation designation.
Is the number of awards known?
The expected number of awards is not provided in the summary. This is noted as common for continuation notices where the recipient pool is already established.
What is the award ceiling for this opportunity?
The opportunity record shows an award ceiling of 0.
Does an award ceiling of 0 mean no funding is available?
Not necessarily. The summary notes that an award ceiling of 0 can appear in system postings when a ceiling is not specified in the summary record, when budgets vary by recipient, or when funding levels are determined through continuation negotiations and appropriations rather than a single fixed cap.
When was the opportunity posted?
The opportunity was created and posted on June 9, 2016.
What was the application closing date?
The original and current closing date listed is August 1, 2016.
What does it mean that the original and current closing dates are the same?
It indicates a single stated deadline for that cycle in the summary record: August 1, 2016.
What kinds of public health improvements does this opportunity aim to support?
It aims to sustain and strengthen capacity and implementation that support preventing new infections, improving early detection, and enhancing prevention and control efforts across HIV/AIDS, viral hepatitis, STDs, and TB, including strengthening the systems that support surveillance, laboratory capacity, and outbreak response.
Is this opportunity focused on one disease or an integrated approach?
The description emphasizes an integrated, multi-disease public health approach covering HIV/AIDS, viral hepatitis, STDs, and TB.
Where should applicants look for the most specific eligibility rules?
The summary states that applicants must consult the additional eligibility field in the full announcement for clarification.
Browse more opportunities from the same agency: HHS-CDC-NCHHSTP
Browse more opportunities from the same category: Health
Next opportunity: Combatting Corruption in the Asia-Pacific Region
Previous opportunity: Cooperative Ecosystem Studies Unit, Rocky Mountain CESU
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 130105CONT17
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 130105CONT17) also looked into and applied for these:
| Funding Opportunity |
|---|
| R40 MCH Secondary Data Analysis Research (SDAR) Apply for HRSA 17 012 Funding Number: HRSA 17 012 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| R40 MCH Field-Initiated Innovative Research Studies (FIRST) Apply for HRSA 17 011 Funding Number: HRSA 17 011 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| PPHF 2016: Preventive Health and Health Services Block Grant – Preventive Health and Health Services Block Grant Apply for CDC RFA OT16 1600PPHF16 Funding Number: CDC RFA OT16 1600PPHF16 Agency: HHS-CDC-OSTLTS Category: Health Funding Amount: Case Dependent |
| Emerging Science and Technology in Transplantation (U01) Apply for RFA AI 16 042 Funding Number: RFA AI 16 042 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Transforming Clinical Practice Initiative (TCPI) Support and Alignment Network (SAN) 2.0 Apply for CMS 1L1 16 001 Funding Number: CMS 1L1 16 001 Agency: HHS-CMS Category: Health Funding Amount: $2,500,000 |
| Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24) Apply for PAR 16 322 Funding Number: PAR 16 322 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21) Apply for RFA HL 17 015 Funding Number: RFA HL 17 015 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| Limited Competition: NIDCR Supplements to NCATS CTSA Programs for Scholars Pursing Dental, Oral and Craniofacial Clinical and Translational Research Career Development (Admin Supp) Apply for RFA DE 17 008 Funding Number: RFA DE 17 008 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Guidance for Supplemental CDC/NCCDPHP/BRFSS Funding Opportunity Announcement (FOA) CDC-RFA-DP15-15130201SUPPPPHF16 Behavioral Risk Factor Surveillance System (BRFSS) Apply for CDC RFA DP15 15130201SUPPPPHF16 Funding Number: CDC RFA DP15 15130201SUPPPPHF16 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $160,000 |
| Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp) Apply for PA 16 328 Funding Number: PA 16 328 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Embassy Conakry Ebola-Related Projects Apply for CKY PAS FY16 002 Funding Number: CKY PAS FY16 002 Agency: DOS-AF Category: Health Funding Amount: $10,000 |
| National HIV Surveillance System (NHSS) Apply for CDC RFA PS13 130205CONT17 Funding Number: CDC RFA PS13 130205CONT17 Agency: HHS-CDC-NCHHSTP Category: Health Funding Amount: Case Dependent |
| Science of Behavior Change: Use-inspired Basic Research to Optimize Behavior Change Interventions and Outcomes (Admin Supp) Apply for PA 16 334 Funding Number: PA 16 334 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| National Accessibility Technical Assistance and Support Apply for P16AS00252 Funding Number: P16AS00252 Agency: DOI-NPS Category: Health Funding Amount: $100,000 |
| Strengthening of Public Health Programs to address Communicable and Non-Communicable Diseases in the Republic of Kenya including the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH16 1703 Funding Number: CDC RFA GH16 1703 Agency: HHS-CDC-CGH Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 17 050 Funding Number: HRSA 17 050 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| NHLBI Pilot Program to Provide Regulatory Support to SBIR/STTR Awardees Developing Medical Devices (Diagnostics and Therapeutics) (Admin Supp) Apply for PA 16 335 Funding Number: PA 16 335 Agency: HHS-NIH11 Category: Health Funding Amount: $5,000 |
| Urban Indian Education and Research Organization Cooperative Agreement Program Apply for HHS 2016 IHS UIHP3 0001 Funding Number: HHS 2016 IHS UIHP3 0001 Agency: HHS-IHS Category: Health Funding Amount: $800,000 |
| Planning Grant for NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (R34) Apply for RFA NS 16 024 Funding Number: RFA NS 16 024 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| Native American Independent Living Demonstration Project Apply for HHS 2016 ACL AOD IL 0184 Funding Number: HHS 2016 ACL AOD IL 0184 Agency: HHS-ACL Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 130105CONT17", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.